First-in-man near-infrared spectroscopy proof of lipid-core embolization during carotid artery stenting

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F16%3A10324958" target="_blank" >RIV/00064203:_____/16:10324958 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/16:10324958

Výsledek na webu

<a href="http://dx.doi.org/10.5114/aoms.2016.60974" target="_blank" >http://dx.doi.org/10.5114/aoms.2016.60974</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5114/aoms.2016.60974" target="_blank" >10.5114/aoms.2016.60974</a>

Jazyk výsledku

angličtina

Název v původním jazyce

First-in-man near-infrared spectroscopy proof of lipid-core embolization during carotid artery stenting

Popis výsledku v původním jazyce

Intravascular near-infrared spectroscopy (NIRS), which has been used in over 5,000 patients to identify the lipid-core plaques (LCP) that cause coronary events, may also assist in the characterization of the carotid atherosclerotic lesions predisposing to stroke. To our knowledge, this is the first report of the use of NIRS in a patient undergoing carotid artery stenting (CAS). In the coronary arteries NIRS seems to be capable of firstly assisting with coronary interventions by predicting distal embolization and stent failure and possibly also to identify lesions at higher risk of causing spontaneous coronary events [1-9]. While NIRS has been cleared by the FDA for detection of LCP in the coronary arteries, it has not been validated or approved for use in carotid arteries [10]. A multimodality catheter (TVC System, Infraredx, Inc, Burlington, MA) that contains intravascular ultrasound (IVUS) and NIRS was used in this carotid case.

Název v anglickém jazyce

First-in-man near-infrared spectroscopy proof of lipid-core embolization during carotid artery stenting

Popis výsledku anglicky

Intravascular near-infrared spectroscopy (NIRS), which has been used in over 5,000 patients to identify the lipid-core plaques (LCP) that cause coronary events, may also assist in the characterization of the carotid atherosclerotic lesions predisposing to stroke. To our knowledge, this is the first report of the use of NIRS in a patient undergoing carotid artery stenting (CAS). In the coronary arteries NIRS seems to be capable of firstly assisting with coronary interventions by predicting distal embolization and stent failure and possibly also to identify lesions at higher risk of causing spontaneous coronary events [1-9]. While NIRS has been cleared by the FDA for detection of LCP in the coronary arteries, it has not been validated or approved for use in carotid arteries [10]. A multimodality catheter (TVC System, Infraredx, Inc, Burlington, MA) that contains intravascular ultrasound (IVUS) and NIRS was used in this carotid case.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2016

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Archives of Medical Science

ISSN

1734-1922

e-ISSN

—

Svazek periodika

12

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

PL - Polská republika

Počet stran výsledku

4

Strana od-do

915-918

Kód UT WoS článku

000379841500030

EID výsledku v databázi Scopus

2-s2.0-84977280300